Alta Natural: New Hep-C Treatment Launched; Sufferers Finally Have a Non-Toxic Choice.BLAINE, Wash.--(BW HealthWire)--May 20, 1999-- Alta Natural (Alberta Stock Exchange Alberta Stock Exchange See Canadian Venture Exchange (CDNX). :AHS AHS Assistant House Surgeon. .) Alta Natural Herbs & Supplements Ltd. will officially launch their clinically researched Hepatitis-C product, "Hepatico" on Tuesday May 25st. This worldwide(x) launch will initially make Hepatico and all of the clinical and pre-clinical trial results published on Hepatico available for the first time from the Company's web sight at www.hepatico.com. Alta's management and medical coordinators have now reviewed all of the data and are pleased to be able to offer this product as an alternative to the current highly toxic highly toxic Occupational medicine adjective Referring to a chemical that 1. Has a median lethal dose–LD50 of ≤ 50 mg/kg when administered orally to 200-300 g albino rats 2. chemotherapy treatment being widely prescribed. Hepatico is clinically established to be completely non-toxic and has not presented any serious side effects Side effects Effects of a proposed project on other parts of the firm. based upon all medical research to-date. 170 million people throughout the world are infected in·fect tr.v. in·fect·ed, in·fect·ing, in·fects 1. To contaminate with a pathogenic microorganism or agent. 2. To communicate a pathogen or disease to. 3. To invade and produce infection in. with the Hepatitis-C virus according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the World Health Organization. The need for treatment alternatives is urgent as currently less than 30% of infected sufferers are successfully treated using established chemotherapy protocol. Members of the media are invited to view the published clinical medical data on-line at www.hepatico.com or by email or fax upon request. Advanced copies of the Tuesday May 25th media release as well as interviews with company officials, medical coordinators and patients are available by contacting Raymond J. Irvine, Vice President, at 800.969.7222. Alta is currently negotiating international distribution agreements that will make Hepatico available throughout the World. (x) Hepatico is not for sale in Canada. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion